TABLE 1.
Patient characteristicsa
| Parameter | No clinical focus of infection
|
Clinical focus of infection
|
||||||
|---|---|---|---|---|---|---|---|---|
| Negative culture (n = 61) | Positive local culture (n = 20) | Positive blood culture (n = 7) | KW Pd | Negative culture (n = 106) | Positive local culture (n = 60) | Positive blood culture (n = 46) | KW Pd | |
| Age (yr)b | 59 (17–89) | 62 (27–89) | 32 (26–56) | <0.005 | 64 (18–92) | 66 (17–97) | 69 (21–92) | NS |
| Genderc | 34/27 | 9/11 | 3/4 | NS | 59/47 | 34/36 | 14/32 | <0.01 |
| HIV and/or AIDS | 3 (5) | 1 (5) | 1 (14) | NS | 9 (8) | 5 (8) | NS | |
| Malignancy | 14 (23) | 6 (30) | 3 (43) | NS | 25 (24) | 6 (10) | 11 (24) | NS |
| Diabetes mellitus | 5 (8) | 1 (5) | NS | 15 (11) | 9 (15) | 14 (30) | <0.05 | |
| Immunocompromising drugs | ||||||||
| Cytostatics | 5 (8) | 3 (15) | 2 (20) | NS | 8 (8) | 2 (3) | 4 (11) | NS |
| Steroids | 8 (13) | 2 (10) | NS | 7 (7) | 2 (3) | 6 (13) | NS | |
| Prior antibiotics | 10 (19) | 5 (33) | NS | 27 (26) | 15 (26) | 10 (22) | NS | |
| Nosocomial fever | 22 (26) | 6 (30) | 1 (14) | NS | 25 (24) | 12 (20) | 17 (37) | NS |
| Time to inclusion (h)b | 13 (1–575) | 7 (1–1,226) | 16 (3–64) | NS | 10 (5–382) | 25 (0–275) | 7 (0–198) | <0.05 |
| Mortality | 6 (10) | 2 (10) | 2 (28) | NS | 2 (2) | 9 (15) | 6 (13) | <0.005 |
a
Unless otherwise specified, results are presented as number (percent). Abbreviations: HIV, human immunodeficiency virus; KW, Kruskal-Wallis test; NS, not significant.
b
Range shown in parentheses.
c
Number of males/number of females.
d
P < 0.005 for presence or absence of a clinical focus of infection versus culture results.